1.Treatment of non-metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone) that has not metastasized (spread to other areas of the body).
2.Treatment of metastatic castration-sensitive prostate cancer (mCSPC).
Product Introduction :
Apalutamide is used to treat certain types of prostate cancer (cancer in men that begins in the prostate [a male reproductive gland]) and has spread to other parts of the body or that has not spread to other parts of the body but has not been helped by other medical treatments. Apalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.
Administration and Dosage :
The recommended dose of apalutamide is 240 mg (four 60 mg tablets) orally once daily, with or without food.